Table 1.
Baseline characteristics, of total cohort, and based on survival status at 1 year
| Characteristic | 1-year mortality |
Total (N = 590) | P | |
|---|---|---|---|---|
| 0 (N = 547) | 1 (N = 43) | |||
| Age, y | 61.2 (15.44) | 64.4 (16.19) | 61.4 (15.51) | 0.1548 |
| Female | 365 (66.7) | 26 (60.5) | 391 (66.3) | 0.4030 |
| PAH subtype | ||||
| iPAH | 274 (51.3) | 23 (53.5) | 297 (51.5) | |
| Heritable | 3 (0.6) | 0 (0.0) | 3 (0.5) | |
| Drug and toxins | 20 (3.7) | 0 (0.0) | 20 (3.5) | |
| CTD | 187 (35.0) | 8 (18.6) | 195 (33.8) | |
| CHD | 30 (5.6) | 3 (7.0) | 33 (5.7) | |
| Portal hypertension | 11 (2.1) | 8 (18.6) | 19 (3.3) | |
| HIV | 4 (0.7) | 0 (0.0) | 4 (0.7) | |
| Low-risk, functional class (WHO FC 1, 2) | 169 (30.9) | 11 (25.6) | 180 (30.5) | 0.4662 |
| Height, cm, mean (SD) | 164.8 (9.81) | 165.0 (11.48) | 164.8 (9.92) | 0.9452 |
| Weight, Kg, mean (SD) | 79.2 (22.33) | 75.8 (20.53) | 79.0 (22.20) | 0.3044 |
| BMI, kg/m2, mean (SD) | 29.1 (7.73) | 27.8 (6.70) | 29.0 (7.66) | 0.3646 |
| Lung transplant | 2 (0.4) | 0 (0.0) | 2 (0.3) | 0.6912 |
Values are n (%), unless otherwise indicated.
BMI, body mass index; CHD, congenital heart disease; CTD, connective tissue disease; HIV, human immunodeficiency virus; iPAH, idiopathic PAH; PAH, pulmonary arterial hypertension; SD, standard deviation; WHO FC, World Health Organization functional class.